DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,104 filers reported holding DANAHER CORPORATION in Q4 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,885,567 | -4.5% | 19,554 | -4.6% | 0.58% | -4.3% |
| Q1 2024 | $5,118,261 | +11.0% | 20,496 | +2.8% | 0.61% | +5.0% |
| Q4 2023 | $4,612,688 | -7.3% | 19,939 | -0.5% | 0.58% | -11.9% |
| Q3 2023 | $4,974,157 | +28.0% | 20,049 | +23.8% | 0.66% | +32.2% |
| Q2 2023 | $3,885,360 | +95339.9% | 16,189 | +0.2% | 0.50% | -7.8% |
| Q1 2023 | $4,071 | -1.8% | 16,152 | +3.5% | 0.54% | -7.1% |
| Q4 2022 | $4,144 | -99.9% | 15,612 | -5.1% | 0.58% | -4.3% |
| Q3 2022 | $4,250,000 | +1.4% | 16,455 | -0.5% | 0.61% | +8.0% |
| Q2 2022 | $4,193,000 | -14.9% | 16,539 | -1.6% | 0.56% | +8.5% |
| Q1 2022 | $4,929,000 | -19.7% | 16,804 | -10.0% | 0.52% | -8.2% |
| Q4 2021 | $6,141,000 | +5.1% | 18,665 | -2.7% | 0.56% | +3.7% |
| Q3 2021 | $5,842,000 | +88.5% | 19,187 | +66.2% | 0.54% | +104.9% |
| Q2 2021 | $3,099,000 | +23.6% | 11,547 | +3.6% | 0.26% | +16.2% |
| Q1 2021 | $2,508,000 | +10.3% | 11,142 | +8.9% | 0.23% | +11.8% |
| Q4 2020 | $2,273,000 | – | 10,229 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |